Federal Supply Schedule 36F79723D0106
Award Date 4/15/23
Last Date to Order 12/31/24
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Department of Veterans Affairs Veterans Integrated Service Network 12 awarded a multiple-award Federal Supply Schedule contract (IDV #36F79722D047E) to Veru Inc., doing business as Veru Healthcare, for the provision of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The contract has a ceiling value of $25,000 and a period of performance through October 2023. Veru Inc. is a for-profit organization and manufacturer of medical goods, including pharmaceuticals,...
- Verrica Pharmaceuticals Inc. (UEI: FE7QAQRN77H1) was awarded a Federal Supply Schedule contract under Schedule 65 IB by the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs, on February 15, 2024. The contract carries a ceiling value of $225,000 and extends through February 14, 2029. This multiple-award Federal Supply Schedule vehicle establishes Verrica as an approved supplier for drugs, pharmaceuticals, and hematology-related...
- The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Verona Pharma, Inc. The contract, with an ID of 36F79724D053E, is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple-award contract with a period of performance through March 14, 2025 and a ceiling value of $25,000.00. As a Federal Supply Schedule contract, this agreement establishes...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Urovant Sciences Inc., a subsidiary of Sumitovant Biopharma, Inc. This multiple-award contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB. The contract has a potential value of $700,000.00 and a period of performance through September 14, 2026. The contract aims to provide the Department...
- Verity Pharmaceuticals, Inc. (UEI: DZMCC17N4ML5) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. This contract, effective December 1, 2021, with an ultimate completion date of November 30, 2026, establishes a $225,000 ceiling value for the delivery of drugs, pharmaceuticals, and hematology-related products. The contract...
- The federal contract IDV awarded to Verrica Pharmaceuticals Inc. is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, with a ceiling value of $25,000 and a period of performance through February 2024. The contract, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12, is for pharmaceutical products including drugs, pharmaceuticals, and hematology-related items. Verrica Pharmaceuticals also holds a $1.25M Blanket Purchase Agreement (BPA) with...
- Fera Pharmaceuticals, LLC, a woman-owned small business specializing in specialty pharmaceuticals for eye health and orphan conditions, was awarded a Federal Supply Schedule contract by the Department of Veterans Affairs Veterans Integrated Service Network 12 on April 15, 2021, for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs schedule (FSS-61-IB). This multiple-award, non-set-aside contract carries a ceiling value of $450,000...
- Urogen Pharma Inc. holds a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) vehicle awarded by Veterans Integrated Service Network 12, with a ceiling value of $225,000 and a performance period extending through December 31, 2026. The contract, established with no set-aside designation on a multiple-award basis, is structured to provide specialized oncology pharmaceuticals to support the Department of Veterans Affairs healthcare system. The primary products...
- The Department of Veterans Affairs Veterans Health Administration awarded a Federal Supply Schedule contract to Vet4U LLC, a service-disabled veteran-owned small business. The $250,000 multiple-award contract, which runs from April 1, 2020 to May 1, 2024, is under the GSA's Medical Equipment and Supplies Schedule 65-II-A. Through this contract, Vet4U provides a variety of medical products to the VA, including pharmaceuticals, medical supplies, personal protective equipment, and other items....
- Verastem, Inc. (Doing Business As Verastem Oncology) has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule, with an effective award date of October 1, 2025, and an ultimate completion date of September 30, 2030. The contract, funded by the Veterans Integrated Service Network 12 (a civilian Veterans Affairs entity), carries a ceiling value of $500,000 and encompasses the procurement of drugs, pharmaceuticals, and...